European Journal of Hospital Pharmacy

Article	Citations
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 2	34
Antifungal drug resistance: an update	34
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19	34
CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions	33
Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System	27
Results of EAHP’s 2019 Medicines Shortages Survey	23
Implementation of a novel home delivery service during pandemic	21
Effectiveness, safety and cost analysis of dalbavancin in clinical practice	21
Cost-effectiveness analysis of pembrolizumab plus standard chemotherapy versus chemotherapy alone for first-line treatment of metastatic non-squamous non–small-cell lung cancer in China	19
Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis	17
Observational study on off-label use of tocilizumab in patients with severe COVID-19	17
Toward a better understanding about real-world evidence	15
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study	13
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19	12
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic	12
Epinephrine use in COVID-19: friend or foe?	12
Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials	11
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report	11
Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series	11
Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital	11
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control	9
Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy	9
External contamination of antineoplastic drug vials: an occupational risk to consider	9
COVID-19 vaccine triggered autoimmune hepatitis: case report	9
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial ch	9

Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results	9
Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study	9
Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance	9
Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: a hospital pharmacy experience	8
Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review	8
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients	8
The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis	8
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment	7
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis	7
Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient	7
Patient prioritisation for hospital pharmacy services: current approaches in the UK	7
Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China	7
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards	6
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence	6
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis	6
Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists	6
Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial	6
Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients	6
What influences the implementation and sustainability of antibiotic stewardship programmes in hospitals? A qualitative study of antibiotic pharmacists’ perspectives across South West England	6
Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients	6
Widening the net: a literature review of antimicrobial agents with potential suitability for outpatient parenteral antimicrobial therapy services—the importance of storage and stability	6
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series	6
Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report	6
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain	6
Managing antibiotic shortages: lessons from EAHP and ECDC surveys	5
Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study	5
Pharmacy preparations and compounding	5
The importance of publishing research protocols for pharmacoeconomic studies	5
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19	5
Red for danger in systematic reviews?	5
Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis	5
Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity	5
An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage	5
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects	5
Dabigatran trough concentrations in very elderly patients	5
Identification and safe storage of look-alike, sound-alike medicines in automated dispensing cabinets	5
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin	5
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study	5
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain	5
RETRACTED: Specific features of rational pharmacotherapy in elderly patients	4
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results	4
Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies	4
Factors influencing the implementation of clinical pharmacy services on paediatric patient care in hospital settings	4
Availability of antidotes in Moroccan hospitals: a national survey	4
Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population	4
Drug-related problems in hospitalised Parkinson’s disease patients in China	4
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care units	4
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements	4
Use of simulation for education in hospital pharmaceutical technologies: a systematic review	4
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients	4

Medication-related problems in critical care survivors: a systematic review	4
Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?	4
Tobramycin and vestibulotoxicity: retrospective analysis of four cases	3
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome	3
5S management improves the service quality in the outpatient-emergency pharmacy: from management process optimisation to staff capacity enhancement	3
Haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with dalteparin	3
Surgical pharmacy: the knowledge system of surgical pharmacists	3
European health data space proposal launched	3
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital	3
Fighting on two fronts: drug–drug interactions in people living with HIV infected with SARS-CoV-2	3
Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance	3
Role of the hospital pharmacist in an Italian antimicrobial stewardship programme	3
Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia	3
Criteria for the selection of paediatric patients susceptible to reconciliation error	3
Defining innovativeness of high-technology medical devices in an Italian region	3
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease	3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document	3
Levofloxacin induced bullous fixed drug eruption: a rare case report	3
Polymyxin B-related neurotoxicity: a brief case report	3
The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic	3
A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib	3
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs	3
Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients	3
Benefit versus toxicity risk of digoxin in patients with COVID-19	3
COvid MEdicaTion (COMET) study: protocol for a cohort study	3
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation	3
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence	2
Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists?	2
Observational study of drug-related problems and clinical pharmacists’ interventions in a French paediatric hospital	2
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze	2
Improving shared decision-making in pharmacist-led haematology clinics: a ‘Plan Do Study Act’ approach	2
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine	2
Successful treatment of Verona integron-encoded metallo-β-lactamase-producingKlebsiella pneumoniaeinfection using the combination of ceftazidime/avibactam and aztreonam	2
Potential costs and consequences associated with medication error at hospital discharge: an expert judgement study	2
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?	2
Antimicrobial resistance in Nigeria: challenges and charting the way forward	2
Tocilizumab in COVID-19 management: addressing time of starting treatment	2
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice	2
Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone – a case report	2
Is sitagliptin effective for the treatment of COVID-19?	2
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic	2
Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients	2
In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion	2
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study	2
Is it safe to use visible blue light-emitting diode phototherapy for neonatal jaundice in infants who are also treated with amiodarone?	2
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide	2
Design and validation of a predictive equation to estimate unbound valproic acid concentration	2
Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation	2
Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series	2
How can we optimise the pharmaceutical analysis of radiopharmaceutical pediatric prescriptions?	2
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA	2
Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study	2
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy	2
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection	2
Global research trends and hotspots in pharmaceutical care: a bibliometric analysis and visualisation using CiteSpace and VOSviewer	2
Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units	2
Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin–angiotensin–aldosterone system inhibitors	2
Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation	2
The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients	2
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison	2
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use	2
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients	2
Drug-related bradycardia precipitating hospital admission in older adults: an ongoing problem	2
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology	2
Clinical pharmacists’ services, role and acceptance: a national Swedish survey	2
Automatic dispensing cabinets and governance of controlled drugs: an exploratory study in an intensive care unit	2
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia	2
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials	2
Development and validation of a ready-to-use score to prioritise medication reconciliation at patient admission in an orthopaedic and trauma department	2
Antimicrobial resistance: a major priority for global focus	2
Therapeutic drug monitoring of linezolid: HPLC-based assays for routine quantification of linezolid in human serum and cerebrospinal fluid	2
Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital	2
Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still’s disease	2
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU	2
Impact of automated dispensing cabinets on dispensing errors, interruptions and pillbox preparation time	2
Analysis of the third WHO Global Safety Challenge ‘Medication Without Harm’ patient-facing materials: exploratory descriptive study	2
Clinical practice and teaching of pharmaceutical care procedures for obstetric diseases	2
Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients withEnterococcus faeciumbacteraemia: a retrospective cohort study	2
Analysis of the clinical characteristics of dabigatran-induced oesophagitis	2
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction	2

Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data	2
Unexpected overdose of oral cyclosporine in a kidney transplant patient: a case report	2
Assessing the quality of drug information provided by hospital pharmacies using a fictitious enquiry and simulated real-life conditions	2
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome	2
Haemolytic anaemia induced by flutamide: a case report	2
Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey	2
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs	2
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors	2
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients	2
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy	2
Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis	2
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure	2
Rational selection of inhalation devices in the treatment of chronic obstructive pulmonary disease by means of the System of Objectified Judgement Analysis (SOJA)	2